Ketoprofen pharmacokinetics, efficacy, and tolerability in pediatric patients

Hannu Kokki1

  • 1Department of Anesthesiology and Intensive Care, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland. hannu.kokki@kuh.fi

Paediatric Drugs
|August 31, 2010
PubMed

Insights

Ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID), effectively manages pain and fever in children. It is well-tolerated and comparable to other treatments for various pediatric conditions.

Area of Science:

  • Pharmacology
  • Pediatrics
  • Pain Management

Background:

  • Ketoprofen is a widely used NSAID for inflammatory conditions, pain, and fever in all age groups.
  • Pharmacokinetic data suggest similar dosing (mg/kg) is appropriate for children and adults.
  • Ketoprofen's ability to cross the blood-brain barrier indicates potential for central analgesic effects.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of ketoprofen in pediatric patients.
  • To compare ketoprofen with other analgesics and placebo in various pediatric pain and fever scenarios.
  • To assess ketoprofen's safety profile in children for short-term use.

Main Methods:

  • Review of clinical trials investigating ketoprofen in children for febrile conditions, peri- and postoperative pain, and inflammatory diseases.
  • Analysis of studies comparing oral, intravenous, intramuscular, and rectal ketoprofen formulations.
  • Examination of adverse event data from studies involving over 900 children.

Main Results:

  • Ketoprofen demonstrated efficacy comparable to acetaminophen and ibuprofen for fever reduction in children.
  • Intravenous ketoprofen was superior to placebo for postoperative pain after adenoidectomy and effective when added to epidural analgesia.
  • Oral ketoprofen showed efficacy in juvenile rheumatoid arthritis and was well-tolerated for up to 3 weeks post-surgery.

Conclusions:

  • Ketoprofen is an effective and well-tolerated option for managing post-surgical pain and inflammatory pain/fever in pediatric patients.
  • Similar pharmacokinetic profiles support comparable mg/kg dosing in children and adults.
  • Adverse events are generally mild and transient, similar to other NSAIDs.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...